Prince of Wales Hospital, Chinese University of Hong Kong, Shatin
Welcome,         Profile    Billing    Logout  
 6 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chan, Matthew
NCT03310125 / 2017-003836-35: Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)

Completed
3
3209
Europe, Canada, US, RoW
Colchicine, Placebo
Population Health Research Institute, Hamilton Health Sciences Corporation
Atrial Fibrillation, Atrial Flutter, Myocardial Injury After Non-Cardiac Surgery
07/23
07/23
DREAM3R, NCT04334759: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

Active, not recruiting
3
214
US, RoW
Durvalumab, MEDI4736, Imfinzi, Standard Chemotherapy, Cisplatin or Carboplatin and Pemetrexed, Ipilimumab and Nivolumab, Yervoy, Opdivo
PrECOG, LLC., AstraZeneca, Thoracic Oncology Group Australasia (TOGA), University of Sydney
Mesothelioma, Pleural Mesothelioma, Malignant Pleural Mesothelioma
06/25
02/26
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
ILLUMINATE, NCT03994393: Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.

Active, not recruiting
2
100
RoW
Tremelimumab, Durvalumab
University of Sydney, AstraZeneca, Australasian Lung Cancer Trials Group
EGFR Mutant Advanced Non Small Cell Lung Cancer
06/23
01/24
GoTHAM, NCT04261855: Targeted Therapy and Avelumab in Merkel Cell Carcinoma

Recruiting
1/2
19
RoW
Avelumab, Bavencio, Anti-PD-L1, External Beam Radiation Therapy (EBRT), Radiotherapy, Lutetium-177 (177Lu)-DOTATATE, Peptide Receptor Radionuclide Therapy (PRRT), Lutathera
Melanoma and Skin Cancer Trials Limited
Metastatic Merkel Cell Carcinoma
07/27
07/27
FAIRAiM, NCT03887897: First Attempt Intubation Rate With Airtraq vs Macintosh Direct Laryngoscope

Recruiting
N/A
1586
RoW
Tracheal Intubation
Chinese University of Hong Kong, Tuen Mun Hospital
Intubation
12/22
12/22
NCT04884802: The GUARDIAN Trial

Recruiting
N/A
6254
Europe, Japan, US, RoW
Tight pressure management, Routine pressure management
The Cleveland Clinic
Blood Pressure
12/26
04/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chan, Matthew
NCT03310125 / 2017-003836-35: Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)

Completed
3
3209
Europe, Canada, US, RoW
Colchicine, Placebo
Population Health Research Institute, Hamilton Health Sciences Corporation
Atrial Fibrillation, Atrial Flutter, Myocardial Injury After Non-Cardiac Surgery
07/23
07/23
DREAM3R, NCT04334759: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

Active, not recruiting
3
214
US, RoW
Durvalumab, MEDI4736, Imfinzi, Standard Chemotherapy, Cisplatin or Carboplatin and Pemetrexed, Ipilimumab and Nivolumab, Yervoy, Opdivo
PrECOG, LLC., AstraZeneca, Thoracic Oncology Group Australasia (TOGA), University of Sydney
Mesothelioma, Pleural Mesothelioma, Malignant Pleural Mesothelioma
06/25
02/26
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
ILLUMINATE, NCT03994393: Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.

Active, not recruiting
2
100
RoW
Tremelimumab, Durvalumab
University of Sydney, AstraZeneca, Australasian Lung Cancer Trials Group
EGFR Mutant Advanced Non Small Cell Lung Cancer
06/23
01/24
GoTHAM, NCT04261855: Targeted Therapy and Avelumab in Merkel Cell Carcinoma

Recruiting
1/2
19
RoW
Avelumab, Bavencio, Anti-PD-L1, External Beam Radiation Therapy (EBRT), Radiotherapy, Lutetium-177 (177Lu)-DOTATATE, Peptide Receptor Radionuclide Therapy (PRRT), Lutathera
Melanoma and Skin Cancer Trials Limited
Metastatic Merkel Cell Carcinoma
07/27
07/27
FAIRAiM, NCT03887897: First Attempt Intubation Rate With Airtraq vs Macintosh Direct Laryngoscope

Recruiting
N/A
1586
RoW
Tracheal Intubation
Chinese University of Hong Kong, Tuen Mun Hospital
Intubation
12/22
12/22
NCT04884802: The GUARDIAN Trial

Recruiting
N/A
6254
Europe, Japan, US, RoW
Tight pressure management, Routine pressure management
The Cleveland Clinic
Blood Pressure
12/26
04/27

Download Options